comparemela.com
Home
Live Updates
Zentalis Regains Worldwide Development - Breaking News
Pages:
Latest Breaking News On - Zentalis regains worldwide development - Page 1 : comparemela.com
Zentalis Pharmaceuticals : Regains Worldwide Development and Commercialization Rights to Azenosertib, ZN-d5 and ZN-c5 As a Result of Termination of Greater China Collaboration and License Agreements - Form 8-K
zntl-20230615 UNITED STATES . | June 15, 2023
Washington
United-states
Taiwan
Delaware
New-york
Macau
China
Hong-kong
Republic-of-china
Taiwan-general
Melissa-epperly
Securities-exchange
vimarsana © 2020. All Rights Reserved.